Emerging therapeutic strategies

Oral cavity and oropharyngeal carcinomas represents a significant cause of morbidity and mortality. In spite of endeavors in improving early finding and treatment, the 5-year endurance pace of cutting edge phase of the illness is under 63%.The field of nanomedicine has offered promising diagnostic and therapeutic advances in cancer. Without a doubt, a few stages have been clinically affirmed for disease treatment, while other promising frameworks are experiencing investigation in clinical preliminaries.With its ability to deliver drugs, nucleic acids, and MRI contrast agents with high efficiency, nanomedicine platforms offer the potential to improve drug efficacy and tolerability. The point of the present smaller than expected audit is to abridge the current preclinical status of nanotechnology frameworks for oral malignant growth treatment.

  • Cancer Nanotechnology
  • Cancer Pharmocology

Related Conference of Emerging therapeutic strategies

June 10-11, 2024

8th Global Meeting on Oncology and Radiology

Barcelona, Spain
July 11-12, 2024

24th World Congress on Cancer and Diagnostics

Vancouver, Canada
July 18-19, 2024

14th World Congress on Breast Cancer

Paris, France
September 16-17, 2024

9th World Conference on Breast and Cervical Cancer

London, UK
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France
November 24-25, 2024

7th International Conference on Anti-Cancer Drugs

Vancouver, Canada

Emerging therapeutic strategies Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in